Regeneron Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US75886F1075

SecurityREGN / Regeneron Pharmaceuticals, Inc.
InstitutionLindbrook Capital, Llc
Latest Disclosed Ownership1,177 shares
Latest Disclosed Value $ 746,489
Lindbrook Capital, Llc reports 2.26% increase in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On May 5, 2025 - Lindbrook Capital, Llc filed a 13F-HR form disclosing ownership of 1,177 shares of Regeneron Pharmaceuticals, Inc. (US:REGN) valued at $746,489 USD as of March 31, 2025. The entity filed a previous 13F-HR on February 6, 2025 disclosing 1,151 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 2.26% during the quarter. The current value of the position is $747,925 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-05-05 2025-03-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 1,177 26 2.26 746 -8.91 0.0688
2025-02-06 2024-12-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 1,151 6 0.52 820 -31.92 0.0740
2024-11-01 2024-09-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 1,145 -14 -1.21 1,204 -1.23 0.1066
2024-07-31 2024-06-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 1,159 40 3.57 1,218 13.09 0.1144
2024-04-25 2024-03-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 1,119 15 1.36 1,077 11.15 0.1008
2024-02-01 2023-12-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 1,104 74 7.18 970 14.40 0.0968
2023-10-25 2023-09-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 1,030 37 3.73 848 18.79 0.0948
2023-07-31 2023-06-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 993 -48 -4.61 714 -16.61 0.0760
2023-04-26 2023-03-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 1,041 79 8.21 855 23.20 0.1002
2023-01-25 2022-12-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 962 34 3.66 694 8.61 0.0855
2022-11-10 2022-09-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 928 34 3.80 639 21.02 0.1078
2022-08-01 2022-06-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 894 -17 -1.87 528 -16.98 0.0873
2022-04-21 2022-03-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 911 13 1.45 636 12.17 0.0982
2022-01-18 2021-12-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 898 -1 -0.11 567 4.23 0.0863
2021-11-05 2021-09-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 899 8 0.90 544 9.24 0.1426
2021-07-27 2021-06-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 891 51 6.07 498 25.44 0.1113
2021-04-28 2021-03-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 840 -39 -4.44 397 -6.59 0.0894
2021-01-27 2020-12-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 879 51 6.16 425 -8.21 0.1039
2020-11-03 2020-09-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 828 -45 -5.15 463 -14.89 0.1275
2020-07-27 2020-06-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 873 11 1.28 544 29.22 0.1614
2020-04-22 2020-03-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 862 -3 -0.35 421 29.54 0.1591
2020-01-27 2019-12-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 865 5 0.58 325 35.98 0.1131
2019-10-30 2019-09-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 860 68 8.59 239 -3.24 0.0903
2019-07-24 2019-06-30 13F REGENERON PHARMACEUTICALS Stock 75886F107 792 -48 -5.71 247 -28.20 0.0953
2019-04-23 2019-03-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 840 0 0.00 344 9.90 0.1370
2019-02-07 2018-12-31 13F REGENERON PHARMACEUTICALS Stock 75886F107 840 840 313 0.1541
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.